Chargement en cours...

Lovastatin corrects excess protein synthesis and prevents epileptogenesis in a mouse model of fragile X syndrome

Many neuropsychiatric symptoms of fragile X syndrome (FXS) are believed to be a consequence of altered regulation of protein synthesis at synapses. We discovered that lovastatin, a drug that is widely prescribed for treatment of high cholesterol, can correct excess hippocampal protein synthesis in t...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Osterweil, Emily K., Chuang, Shih-Chieh, Chubykin, Alexander A., Sidorov, Michael, Bianchi, Riccardo, Wong, Robert K. S., Bear, Mark F.
Format: Artigo
Langue:Inglês
Publié: 2013
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3597444/
https://ncbi.nlm.nih.gov/pubmed/23352161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.neuron.2012.01.034
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!